FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

162 letters match. Newest first.

  1. Diamond Distributions LLC

    Diamond Distributions LLC lacked a Foreign Supplier Verification Program for imported chocolate products, FDA found after a May 2026 inspection.

    Medium
  2. Skytron, LLC

    Skytron marketed four UV disinfection devices without FDA clearance or approval and kept unapproved medical claims after promising to remove them.

    High risk
  3. Genzyme Ireland Limited

    Genzyme Ireland's Waterford biologics plant cited for quality unit and data integrity failures across two licensed products.

    High risk
  4. AseptiKits, LLC

    AseptiKits marketed unapproved sterile-preparation device kits without FDA clearance or approval, FDA says.

    High risk
  5. 3B Medical, Inc. dba Reach Health, Inc.

    FDA warns Reach Health over unapproved APAP use change and complaint/CAPA failures.

    High risk
  6. BMC Medical Co., Ltd.

    BMC Medical’s G3X APAP devices were misbranded/adulterated after significant changes without a new 510(k) and an unreported firmware fix.

    High risk
  7. Flax & More Corporation

    FDA warned Flax & More Corporation that its dietary supplements were made under conditions that failed required manufacturing quality rules.

    High risk
  8. Imu-Tek Animal Health, Incorporated

    FDA warns Imu-Tek Animal Health over unapproved drug claims and manufacturing failures for Colostrom-5 products.

    High risk
  9. Jubilant HollisterStier General Partnership

    FDA found sterile drug manufacturing and investigation failures at Jubilant HollisterStier in Kirkland.

    High risk
  10. Momentum Health 360 dba Momentum Health

    FDA warned Momentum Health over false claims for compounded semaglutide, tirzepatide, and liraglutide.

    Low
  11. Pharmathen International S.A.

    FDA warns Pharmathen over inadequate aseptic controls at its Greek plant making sterile drugs for the U.S.

    High risk
  12. ZOLL Medical Corporation

    FDA warned ZOLL Medical after an inspection found quality-system, design-validation, supplier, and reporting failures for defibrillators, ventilators, and electrodes.

    High risk
  13. Hubei Gedian Humanwell Pharmaceutical Co., Ltd.

    FDA: Hubei Gedian Humanwell API plant has scratched, stained equipment and weak quality unit oversight.

    High risk
  14. Revlon Group Holdings, LLC

    FDA cited Revlon's Oxford, NC over-the-counter drug plant for failing to test talc for asbestos and weak quality oversight.

    High risk
  15. Medline Inc

    FDA warned Medline Inc about repeated Bacillus cereus contamination in its drug products and inadequate investigations.

    High risk
  16. Laboratorios Jaloma S.A. de C.V.

    FDA found Laboratorios Jaloma’s OTC drug lab records were inaccurate, microbial tests unvalidated, and electronic data missing or uncontrolled.

    High risk
  17. City Market, Inc.

    FDA cited City Market, Inc. for insanitary conditions and seafood safety plan (HACCP) failures involving ready-to-eat pasteurized canned crab meat.

    High risk
  18. GC America, Inc.

    FDA warned GC America after an inspection found inadequate component testing, stability data, and quality oversight for its OTC drugs.

    High risk
  19. Best Buy Bones, Inc.

    Best Buy Bones pet treats were found with Salmonella and serious animal-food safety and CGMP violations.

    High risk
  20. IDO Pharm Co., Ltd.

    IDO Pharm, South Korean drug manufacturer, cited for good manufacturing practice violations including unvalidated system and test methods.

    High risk
  21. OptiHealth Products, Inc.

    FDA warned OptiHealth Products over website claims that Super Antioxidant (OPCXtra) is a drug for diseases like diabetes and Alzheimer's.

    Low
  22. Minh Phung, Inc.

    FDA warns Minh Phung, Inc. over insanitary conditions and time-temperature abuse in refrigerated rice noodles and rice cakes.

    High risk
  23. CareFusion 213, LLC

    FDA warns CareFusion 213 over inadequate investigations and contamination controls at its El Paso sterile drug plant.

    High risk
  24. Active Cosmetics Manufacturing Inc.

    FDA cited Active Cosmetics Manufacturing for releasing topical OTC drugs after microbial contamination without thorough investigations.

    High risk
  25. Respilon Production S.R.O.

    FDA found Respilon, a Czech OTC drug maker, lacked ingredient identity testing, stability data and process validation.

    Medium
  26. Unetixs Vascular, Inc.

    Unetixs Vascular marketed modified ROODRA and 2CP vascular diagnostic devices without required FDA clearance.

    High risk
  27. DO&CO Aktiengesellschaft/DO&CO, Inc.

    DO&CO airline catering facilities in New York and Michigan had repeated Listeria monocytogenes contamination and sanitation failures.

    High risk
  28. Intelligent Remedies, Inc.

    FDA warned Intelligent Remedies that disease-treatment claims make nine products unapproved new drugs.

    High risk
  29. Aaa International Seafood Corp.

    Aaa International Seafood Corp. fresh tuna and salmon were adulterated due to seafood HACCP and importer verification failures.

    High risk
  30. Intas Pharmaceuticals Limited

    FDA warns Intas Pharmaceuticals' Dehradun, India plant over weak out-of-spec investigations and untracked batch-record edits for its tablets.

    High risk
  31. Nupack Inc.

    FDA warned Nupack Inc. that its dietary supplements were unapproved drugs and made without required manufacturing-practice records.

    High risk
  32. New Life Pharma LLC

    New Life Pharma made unapproved semaglutide and tirzepatide sterile vials without sterility controls and refused FDA access to some areas.

    High risk
  33. RC Outsourcing, LLC

    FDA warned outsourcing facility RC Outsourcing of Lowellville, Ohio, that its sterile drugs were made under insanitary conditions that risk contamination.

    High risk
  34. Half Hill Farm Inc.

    FDA cited Half Hill Farm's mushroom extracts as unapproved new drugs over website disease-treatment claims.

    Low
  35. Ocean Group Inc.

    FDA found Listeria monocytogenes and seafood HACCP sanitation violations at Ocean Group's ready-to-eat salmon and tuna facilities.

    High risk
  36. Medline Industries, LP

    Medline's Glen Falls, NY plant made angiographic syringes and kits under flawed CAPA, cleaning and design verification controls, FDA says.

    High risk
  37. Microbiological Testing & Consulting, LLC

    FDA warned contract testing lab Microbiological Testing & Consulting over CGMP violations in drug product microbiological testing.

    High risk
  38. Physitemp Instruments, LLC

    FDA says Physitemp sold clinical thermometers and temperature probes without FDA clearance and with unvalidated sterilization and welding.

    High risk
  39. Yangzhou H&R Plastic Daily Chemical Co., Ltd.

    Yangzhou H&R Plastic Daily Chemical, a Chinese contract manufacturer, lacked release testing and CGMP controls for its OTC drug.

    High risk
  40. Longhorn Vaccines and Diagnostics LLC

    Longhorn Vaccines and Diagnostics sold its PrimeStore MTM sample transport device without required quality controls or clearance for claims beyond its approved uses.

    High risk
  41. IsoTis OrthoBiologics, Inc.

    IsoTis OrthoBiologics in Irvine, CA failed to properly fix and assess possible particulate contamination in its Accell bone filler devices, FDA says.

    High risk
  42. OraLabs, Inc.

    FDA warned OraLabs, an OTC drugmaker in Parker, Colorado, that it skipped microbial release testing and dismissed contamination findings.

    High risk
  43. JZ Wholesale, Inc.

    FDA warned JZ Wholesale after finding widespread rodent and insect contamination in food at its Fort Smith, Arkansas warehouse.

    High risk
  44. Avertix Medical, Inc.

    FDA warns Avertix Medical over Guardian implantable cardiac event detector quality violations and late injury reports.

    High risk
  45. Novo Nordisk Inc.

    FDA warns Novo Nordisk over failures to report and investigate serious unexpected adverse drug experiences for drugs including semaglutide.

    High risk
  46. Simtra BioPharma Solutions

    FDA found contamination risks in Simtra's sterile drug manufacturing in Germany, including microbial recoveries, failed isolator tests, and inadequate decontamination.

    High risk
  47. Rio Verde Food Service Inc.

    FDA warns Rio Verde Food Service that its live oyster safety plan lacks temperature controls needed to prevent pathogens.

    High risk
  48. R.R. Importaciones Inc.

    FDA found R.R. Importaciones Inc. lacked required foreign food supplier verification, including for chocolate.

    Medium
  49. The Father's Table, LLC

    FDA warned The Father's Table that its ready-to-eat cheesecakes and cake rolls were adulterated after Listeria monocytogenes was found in the facility.

    High risk
  50. John Yoder Farm

    FDA warns John Yoder Farm over shell eggs and missing Salmonella prevention plan.

    High risk